Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus

Cancer Immunology Immunotherapy

Volumn 47, Issue 1, 1998, Pages 21-31

  Akagi, Junji ^a   Nakagawa, Kazuhiro ^a   Egami, Hiroshi ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; CTL; DF3 MUC 1; Immunotherapy; Vaccinia virus

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLORECTAL CANCER; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; TANDEM REPEAT; VACCINIA VIRUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MEMBRANE GLYCOPROTEINS; MICE; MONOCYTES; REASSORTANT VIRUSES; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 0031691158     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050500     Document Type: Article

References (27)

1. Acres RB, Hareuveini M, Balloul J-M, Marie-Paulekieny (1993) Vaccinia virus MUC-1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC-1 antigen. J Immunother 14:136
2. Akagi J, Hodge JW, McLaughlin JP, Gritz L, Panicali D, Kufe D, Schlom J, Kantor JA (1997) Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC-1 gene and the murine T-cell costimulatory molecule B7. J Immunother 20:38
3. Andrews CW, Jessup JM, Goldman H, Hayes DF, Kufe DW, O'Hara CJ, Steele G (1993) Localization of tumor-associated glycoprotein DF3 in normal, inflammatory and neoplastic lesions of the colon. Cancer 72:185
4. a epitope on distinct core porteins. J Biol Chem 266:21537
5. Baeckstrom D, Nilsson O, Price MR, Lindholm L, Hansson GC (1993) Discrimination of MUC1 mucins from other sialyllea-carrying glycoproteins by colon carcinoma cells using a novel monoclonal antibody. Cancer Res 53:755
6. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1969) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T-cells. Proc Natl Acad Sci USA 86:7159
7. Bruggen P van de (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643
8. Burchell J, Taylor-Papadimitriou J, Bosheel MSG, Duhig T (1989) A short sequence, within the amino-acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 44:691
9. Disis ML (1994) Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54:16
10. Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaola T (1986) Helper T cells against tumor-associated antigens (TAA): preferential induction of helper-T-cell activities involved in anti-TAA cytotoxic-T-lymphocyte and antibody response. J Immunol 136:2715
11. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J (1989) A core protein epitopc of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43:1072
12. Glimcher LH, Longo DL, Green I, Schwartz RH (1981) Murinc syngeneic mixed lymphocyte response I. Target antigens arc self Ia molecules. J Exp Med 154:1652
13. - lymphocytes. J Exp Med 154:952
14. Hareuveni M, Tsarfaty J, Zaretsky J, Kotkes P, Horev P, Zrihner S (1990) A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen: cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue. Eur J Biochem 189:475
15. Hayes DF, Zurawski VRJ, Kufe D (1986) Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 4:1542
16. X with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res 55:3659
17. Hsu MS, Raine L, Fanger H (1982) The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29:577
18. Hu S-L, Plowmanm GD, Sridhar P, Stevenson US, Brown JP, Estin CD (1988) Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97. J Virol 62:176
19. Hull SR, Bright A, Carraway KL, Abe M, Hayes DF, Kufe D (1989) Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun 1:261
20. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast RC, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognized an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908
21. Kantor JA, Irvine K, Abrams S, Kaufman H, DiPietro J, Schlom J (1992) Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst 84:1084
22. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54:2856
23. Lan MS, Batra SK, Qui W-N, Metzgar RS, Hollingsworth MA (1990) Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 265:15294
24. Robbins PF, Kantor J, Salgaller M, Hand PH, Fernstern PD, Schlom J (1991) Cancer Res 51:3657
25. Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calno F, and Soussi T (1992) The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 52: 6380
26. Zrihan-Licht S, Baruch A, Elroy-Stein O, Keydar I, Wreschner DH (1994) Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins: cytokine receptor-like molecule. FEBS Lett 356:130
27. Zrihan-licht S, Vos HL, Baruch A, Elroy-Stein O, Sagiv D, Keydar I, Hilkens J, Wreschner DH (1994) Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeals, expressed in human breast cancer tissue. Fur J Biochem 224:787